American Bio Medica Debuts Its Retail Drug Detector.

Business Editors/Biotechnology Writers

KINDERHOOK, N.Y.--(BUSINESS WIRE)--June 21, 2000

Introduces Spray Test at Chain Drug Stores' Conference

American Bio Medica Corp. (NASDAQ: ABMC), which develops, manufactures and markets drugs-of-abuse diagnostic kits, sprays and support services, will introduce its first over-the-counter product at the National Association of Chain Drug Stores Marketplace trade show in New Orleans June 25 - 28.

ABMC will demonstrate its wipe-and-spray Drug Detector(TM) that tests for the presence or absence of crack/cocaine or marijuana residue on surfaces, such as desk tops, book bags and steering wheels. The patented Drug Detector kit includes an aerosol spray for either crack/cocaine or marijuana, 10 collection papers and instructions. It's easy to use -- just wipe any surface with a collection paper and spray the paper with the aerosol can. If it detects the drug residue, the paper will turn blue for cocaine and reddish brown for marijuana within seconds.

In about two months, ABMC will offer the Drug Detector for methamphetamine and heroine, in addition to the cocaine and marijuana tests, in larger, industrial-size versions of 50-100 tests.

"We are delighted to introduce our first OTC product at this very important gathering of retailers," said ABMC Chairman and CEO Stan Cipkowski. "We consider Drug Detector a break-through product for the retail market that will enable parents, spouses and other responsible parties to detect drug use with or without the person's knowledge. This is the market's first, completely reliable, arms-length drug test for the most commonly abused drugs."

ABMC has a second product ready for retail release pending FDA approval of over-the-counter sales: Rapid Drug Screen(TM) on-site tests that generate results in five minutes and are unrivaled in the market for ease of use. Each test kit includes a plastic cup with an affixed temperature strip and secure lid for a urine sample. One or more Rapid Drug Screen test cards are inserted into the urine through a safety-sealed slit in the cup lid and, in minutes, indicate the presence or absence of the drugs covered by the cards: cocaine, opiates, marijuana, PCP, barbituates, benzodiazepines, tricyclic antidepressants, methamphetamine, amphetamines and methadone individually or in various combinations. Rapid Drug Screens are already in use at the institutional level by clinicians, educators, government, judiciary and business customers, and are proven to correlate 100% with the standard laboratory test.

More than 1,000 companies are expected to be represented at the Chain Drug Stores Marketplace this year. This will be the first time ABMC has participated in the show and its representatives look forward to meeting visitors at booth #1682

American Bio Medica Corporation develops, manufactures and markets inexpensive, accurate, on-site drugs-of-abuse diagnostic kits, sprays and supports services worldwide. The company's global distributors target the workplace, clinical, physicians, corrections and educational markets.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence on third-party suppliers, intellectual property rights and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.